Aurinia Pharmaceuticals Inc.
AUPH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $5,752 | -$78,020 | -$108,180 | -$180,966 |
| Dep. & Amort. | $19,445 | $11,647 | $2,706 | $2,761 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $31,596 | $45,311 | $32,300 | $31,243 |
| Change in WC | $5,448 | -$5,608 | -$6,817 | -$21,633 |
| Other Non-Cash | -$17,853 | -$6,791 | $462 | $10,903 |
| Operating Cash Flow | $44,388 | -$33,461 | -$79,529 | -$157,692 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$281 | -$718 | -$292 | -$1,501 |
| Net Acquisitions | $0 | $0 | $0 | -$1,204 |
| Inv. Purchases | -$545,832 | -$523,500 | -$523,993 | -$438,958 |
| Inv. Sales/Matur. | $585,418 | $529,376 | $464,316 | $354,427 |
| Other Inv. Act. | -$43 | -$11,864 | -$663 | -$16,634 |
| Investing Cash Flow | $39,262 | -$6,706 | -$60,632 | -$103,870 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$11,989 | -$10,025 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $196,740 |
| Stock Repurch. | -$40,239 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $3,136 | $4,895 | $2,433 | $24,372 |
| Financing Cash Flow | -$49,092 | -$5,130 | $2,433 | $221,112 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $34,558 | -$45,297 | -$137,728 | -$40,450 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $48,875 | $94,172 | $231,900 | $272,350 |
| End Cash | $83,433 | $48,875 | $94,172 | $231,900 |
| Free Cash Flow | $44,107 | -$34,179 | -$79,821 | -$159,193 |